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http://dx.doi.org/10.1016/j.asjsur.20Summary Background/Objective: As renal transplantation may increase survival rates and
improve quality of life for children with end-stage renal disease, we investigated the long-
term outcomes and prognostic factors of pediatric renal transplantation.
Methods: A retrospective study was conducted to review 25 pediatric renal transplantations,
either from live or deceased donors, in our hospital from 1995 to 2008. The cumulative graft
survival rate was calculated using the Kaplan-Meier method. Log rank tests were employed
to identify categorical prognostic factors for graft survival of the pediatric renal transplanta-
tions, and Cox regression analysis for numeric factors.
Results: The mean age of our study subjects was 11.63  3.76 years, and the mean follow-up
period was 49.24  33.72 months. The 12-month and 36-month graft survival rates were 92%
and 82.14%, respectively. The rejection-free survival rates were 88% and 72.88% in the first
and third years, respectively. All of the patients were alive during the follow-up period. Acute
rejection (pZ 0.0175) and male sex (pZ 0.0384) were found to be significant factors for graft
survival.
Conclusion: For pediatric patients, we found that renal transplantation is now a safe and
effective surgical procedure for children with end-stage renal disease. Acute rejection and
male gender were identified as prognostic factors for poor graft survival.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Surgery, National Taiwan University Hospital, Number 7, Chung-Shan South Road, Taipei, Taiwan.
edu.tw (M.-K. Tsai).
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nephrectomy. The donor artery was anastomosed to theRenal replacement therapy for pediatric patients with end-
stage renal disease can be difficult. Children on dialysis,
either peritoneal dialysis or hemodialysis, have a higher
incidence of morbidity and mortality.1 In addition, renal
transplantation in pediatric patients seems to be
associated with more technical complications and poorer
graft survival than in adults.2,3 Recently, Tangeraas et al4
reported that early transplantation can provide better
prospects for survival, growth, and development in infants
or small children than maintenance on chronic dialysis.
Since uremia in children is associated with developmental
delays and encephalopathy, many studies agree that renal
transplantation should be performed as soon as possible.1,4,5
Renal transplantation is an effective treatment for
children with end-stage renal disease to improve the
survival rate and growth development.5,6 Recent advance-
ments in immunosuppressive drugs and surgical techniques
have improved the prognosis of pediatric renal trans-
plantation, and a successful outcome depends on many
factors such as the use of an adult living donor, delicate and
skilled operative procedure, peri- and postoperative care,
early or preemptive transplant, and long-term follow
up.4,7,8 However, graft failure and death continue to occur
as a result of infection, rejection, and adverse events from
drugs.5,9e11 Children and adults differ in terms of biology
and psychology, and their patterns of nonadherence to
medications are also distinct.11e13
In this study, we aimed to investigate the experience in
our hospital with regard to the long-term outcomes of
pediatric renal transplantation from 1995e2008 by evalu-
ating the impact of different factors on graft survival and
rejection-free survival rates, and then to identify risk or
prognostic factors.
2. Methods
The medical records of children aged younger than 18 years
who received a renal transplant between January 1995
and December 2008 were retrospectively reviewed. There
were 25 transplants in 24 patients enrolled in the cohort
study. Each transplantation was regarded as independent;
therefore, we analyzed patient and graft survival rates in 25
transplantations. We retrieved information on recipient age,
recipient sex, native renal disease, donor characteristics,
mismatches of human lymphocyte antigens (HLAs), vascular
anastomosis sites, patient and graft survival, acute rejection
episodes, cause of graft failure, and cause of death. Graft
failure was defined as failure of a renal transplant, return to
dialysis, or finalizing the date for a new preemptive trans-
plantation. Acute rejection episodes were defined as a rise
in serum creatinine of at least 30% from baseline levels and
accompanied by clinical symptoms and signs, including fever
and oliguria. Rejection could also be diagnosed on the basis
of pathologic proof with a renal biopsy.
All grafts were placed extraperitoneally in the iliac
fossa. A modification of the approach used for renal
transplantation in adults was used. Ipsilateral nephrectomy
was performed if the extraperitoneal space was inadequate
to accommodate the grafts. Live donor grafts wereharvested by laparoscopic nephrectomy or traditional
external iliac artery, common iliac artery, internal iliac
artery, or descending aorta; the site depended on graft size
and relative anatomy and was made tension free by using
the running suture technique. Venous anastomosis was
performed using the same method and connected to the
external iliac vein, common iliac vein, or inferior vena
cava. When the kidney graft showed two arteries, the
vessels were anastomosed using connecting patches to
allow for a single anastomosis.
To overcome the size discrepancies between kidneys
from adult donors and small child recipients, wound closure
was performed using an absorbable mesh of polyglactin
910, a synthetic copolymer made from 90% glycolide and
10% L-lactide (Vicryl Mesh, Johnson & Johnson Interna-
tional, Brussels, Belgium) to avoid organ compression, and
the skin was primarily closed.14 If the patient had been
undergoing peritoneal dialysis prior to renal trans-
plantation, then the catheter was preserved and removed
once the graft being functioning. Ureteroneocystostomy
was performed using the Lich-Gregoir procedure with
interrupted sutures to implant the graft ureter into the
recipient’s urinary bladder.14,15
Immunosuppression was induced in all patients with
either a cyclosporine- or tacrolimus-based regimen con-
sisting of 8e10 mg/kg/day of cyclosporine or 0.15e0.3 mg/
kg/day of tacrolimus. The doses were adjusted to maintain
a trough whole blood concentration of 300e400 ng/mL for
cyclosporine or 8e12 ng/mL for tacrolimus. No antibody-
depleting agents were used for induction. A bolus dose of
intravenous methylprednisolone (10 mg/kg) was given
before vascular reperfusion, with tapering to 0.5 mg/kg/
day oral prednisolone by Day 8. The steroids were stopped
after 3 months. Mycophenolate mofetil was used at 40 mg/
kg/day given in divided doses from 1998 in our hospital. The
white blood cell counts were maintained above 4000/mm3.
Methylprednisolone pulse therapy (10 mg/kg/day for 3
days) was the primary therapy for acute rejection.
Continuous variables were described as mean values and
ranges, and categoric data by proportions. Log rank tests
were employed to identify categorical prognostic factors
for graft survival of pediatric renal transplantation, and Cox
regression analysis for numeric factors. Prognostic factors
including acute rejection, gender, age at transplantation,
donor type, donor age, and HLA mismatch were analyzed
using NCSS statistical analysis and graphics software 2000
for Windows.3. Results
There were 25 transplantations, 14 of whom were boys
(56%) and 11 were girls (44%) with a mean age of
11.6  3.76 years (range 1.75e16 years; Table 1). Among
the study participants, one patient underwent renal and
heart transplantation and one had undergone renal trans-
plantation twice. Most of the recipients underwent the
transplant between 12 and 15 years of age, followed by
those aged 7e11 years.
All of the patients had end-stage renal disease
before transplantation. The diagnoses included chronic
Table 1 Age distribution of the transplant recipients.
Patients, n <2 yr 2e6 yr 7e11 yr 12e15 yr 16e18 yr
Male 1 0 2 10 1
Female 0 1 6 2 2
Pediatric renal transplantation 55glomerulopathy (n Z 5), lupus nephritis (n Z 2), reflux
nephropathy (n Z 1), angiomyolipoma (n Z 1), polycystic
disease (nZ 1), bilateral renal artery stenosis (nZ 1), and
congenital renal hypoplasia (n Z 1). However, for more
than one-half of the patients (n Z 13), the underlying
etiology was unknown. The patients underwent renal
replacement therapy including hemodialysis (40%), perito-
neal dialysis (16%), alternating between hemodialysis and
peritoneal dialysis (8%) and without treatment (36%) before
transplantation.
There were 15 living donor transplantations (60%), and
the mean age of the donors was 40.8 years (25e50 years).
There were 10 deceased donor transplantations (40%), and
the average age of the deceased donors was 22.8 years
(7e44 years). The HLA mismatches ranged from 1 to 6, and
the average was 3  0.6. The most common vascular
anastomosis sites were the external iliac artery (60%) and
the external iliac vein (68%) to the renal artery and renal
vein (Table 2). Other artery anastomosis sites were the
common iliac artery (24%), internal iliac artery (8%), and
descending aorta (8%). Besides the external iliac vein, the
common iliac vein (16%) and inferior vena cava (16%) were
chosen as the venous anastomosis site. Only one person
with transplantation received ipsilateral nephrectomy.
After renal transplantation, the mean serum creatinine
level on postoperative Day 7 was 1.14  0.72 mg/dl. All
of the patients in this study series had immediate graft
function. The average follow-up period was 49.24  33.72
months. There was no surgical mortality and all of the
patients were alive during the follow-up period. The 1-,
2- and 3-year graft survival rates were 92%, 87.62%, and
82.14%, respectively, and the 1-, 2- and 3-year rejection-
free survival rates were 88%, 78.96%, and 72.88%,
respectively.
There were four graft failures after transplantation; the
first case was an 11-year-old boy who underwent renal
transplantation twice. In his case, graft failure occurred
the first time due to venous thrombosis. Although the
second graft was followed-up for 9 months, failure resulted
due to acute rejection with ureter stricture. Thus, this case
accounted for the failure of two grafts resulting from two
surgical complications. Another surgical complication,
urinary leak, occurred in a 1-year, 8-month-old recipient.
Fortunately, revision ureteroneocystostomy solved the
problem and rescued the graft. A third case of graft loss
occurred in a 15-year-old boy who had acute rejection 34Table 2 Vascular anastomosis sites.
Vascular anastomosis (n Z 25) Artery Vein
External iliac/internal iliac 15/2 17/0
Common iliac 6 4
Aorta/inferior vena cava 2/0 0/4months after transplantation. The fourth graft loss was in
a 13-year-old girl who was followed-up for 18 months; in
her case, acute rejection was also the main reason for graft
failure.
The other postoperative complications in our patients
were mostly infections, including pneumonia n Z 4),
urinary tract infection (n Z 3), acute gastroenteritis
(n Z 3), and other miscellaneous infections. All of the
infectious complications were successfully treated with
antimicrobial agents and support treatment. One of our
patients had post-transplant lymphoproliferative disease
(B cell lymphoma) and was cured using monoclonal ritux-
imab antibodies, which target the CD20 marker on B
lymphoma cells. All of the post-transplant complications
are listed in Table 3.
Survival analysis was performed to identify the prog-
nostic factors for renal transplant graft survival (Table 4). In
our cohort study, a total of six cases were compatible with
acute rejection. There were four cases of acute cellular
rejection and one of acute cellular rejection with antibody
mediated rejection by pathological diagnosis. Only one
case was diagnosed by clinical diagnosis, and this case
responded to steroid pulse therapy. Acute rejection and
recipient gender were found to be significant prognostic
factors for graft survival (p Z 0.0175 and 0.0384, respec-
tively). The 3-year graft survival rates for patients with and
without acute rejection were 50.00% and 94.74%, respec-
tively. The male and female patients had 64.29% and 100%
graft survival rates, respectively, at 3 years. The patients
who had live and deceased donors had 92.31% and 66.67% 3-
year graft survival rates, respectively. Neither donor source
nor immunosuppressive drugs were significant prognostic
factors for graft survival, which may be explained by the
small sample size and different follow-up periods.
Patient age, donor age, and HLA mismatch were not
significant factors for graft survival.4. Discussion
Children with end-stage renal disease can receive long-
term dialysis therapy; however, the mortality rate for these
children is estimated to be 30 times higher than for those
without chronic kidney disease, and four times higher than
for those who receive renal transplantation.1 Renal trans-
plantation is a safe and effective surgical procedure to help
children with end-stage renal disease. In our series, no
patients died during the transplant follow-up period, and
the 3-year graft survival rate was 82.14%, compatible with
that of the University of Minnesota.4 Nevertheless, all of
our patients had immediate graft function, suggesting that
the operative techniques, including live donor nephrec-
tomy, deceased donor nephrectomy and transplantation for
the recipients, were effective.
Overcoming the size discrepancy between small pedi-
atric recipients and large adult organs is essential for the
success of pediatric renal transplantation. We used an
absorbable mesh to facilitate closure of the abdominal
wound without compression of the graft. In addition, with
the application of absorbable mesh, pediatric recipients
may not need to receive ipsilateral nephrectomy to
increase the abdominal capacity. In our series, the youngest
Table 3 Post-transplant complications in the pediatric renal transplantations (n Z 25).
Complications Diagnosis Patients, n (%)
Surgical Renal vein thrombosis 1 (4.0)
Ureter implantation/urinary leakage 2 (8.0)
Oncological Post-transplant lymphoproliferative disease 1 (4.0)
Infectious Bronchopneumonia/pneumonia 4 (16.0)
Urinary tract infection 3 (12.0)
Acute gastroenteritis 3 (12.0)
Wound abscess 1 (4.0)
Epididymitis 1 (4.0)
Chickenpox 1 (4.0)
Herpes simplex 1 (4.0)
Acute otitis media 1 (4.0)
56 P.-C. Huang et al.recipient was aged 1 year and 8 months, and he did not
require ipsilateral nephrectomy to receive his mother’s
kidney. Ipsilateral nephrectomy was conducted in only one
case, a 2-year-old girl only weighing 10 kg who received
a large renal graft from her father who weighed 70 kg.16
Ipsilateral nephrectomy, which increases the transplant
operation time and risk, may therefore be omitted from
pediatric renal transplantation.
As we did not routinely remove the ipsilateral native
kidney, we performed vascular anastomosis mostly in the
external iliac artery and vein, instead of the inferior vena
cava and descending aorta. It has been reported that
a higher success rate can be achieved in pediatric renal
transplantation when the site of vascular anastomosis is the
inferior vena cava and descending aorta rather than the
external iliac artery and vein.9,14 However, we had a low
incidence of vascular complications and acceptable
outcomes employing mesh repair to accommodate the
relatively protruding low poles of the graft kidneys. In
addition, we believe that an extraperitoneal approach to
pediatric renal transplantation can facilitate wound
closure, early feeding and oral immunosuppression, which
are all extremely important for the success of pediatric
renal transplantations.14,17
In this study, acute rejection and recipient sex were
found to be statistically significant factors by log-rankTable 4 Survival analysis for the prognostic factors of renal tra
Log-rank test Category Patie
Acute rejection Positive 6
Negative 19
Recipient sex Male 14
Female 11
Donation source Living 15
Deceased 10
Immunosuppressiona Tacrolimus 17
Cyclosporine 7
Cox’s regression Regression coefficient
Donor age (yr) 0.0383
HLA mismatch 0.1948
Recipient age (yr) 0.0338
HLA Z human lymphocyte antigen.
a One patient with renal vein thrombosis did not receive immunosuanalysis. Since renal function can be damaged by allograft
rejection, acute rejection should be the decisive factor
for the long-term outcomes of renal transplantations.
Interestingly, male gender was also a significant prognostic
factor for pediatric renal transplantation. Six patients
experienced acute rejection in our series, of whom four
were boys. Based on the history taken from family members
and the patients’ immunosuppressive drug levels, non-
adherence to the immunosuppressive regimens was highly
suspected as the reason for acute rejection and graft
failure.
Nonadherence to immunosuppressive medications is one
of the main factors contributing to graft rejection, graft
loss, and mortality.12,18 An inexplicably low trough level of
immunosuppressive drugs is proof that medications have
been omitted. On the other hand, an unexpectedly high
level also indicates non-adherence to the medications. We
hypothesize that boys tend to be more active and are thus
less likely to adhere to the immunosuppressive drugs.12
However, we did not have any standardized methods of
assessing adherence in this study.
As for donor source, pediatric transplants from deceased
donors have been reported to have higher acute rejection
rates than those from live donors.4,7,9 Live donors, there-
fore, should be a better source of choice to avoid acute
rejection in pediatric renal transplantation. However, thensplant graft survival.
nts, n 3-yr graft survival, % p value
50.00 0.0175
94.74
64.29 0.0384
100.00
92.31 0.1307
66.67
93.33 0.1921
71.43
Standard error Risk ratio p value
0.0380 0.9624 0.3385
0.4302 1.2151 0.6599
0.1388 1.0344 0.8027
ppressive drugs.
Pediatric renal transplantation 57difference in graft survival rates between living (92.31%)
and deceased (66.67%) donors did not reach statistical
significance in our study, although this may be because our
patient number was small.
In conclusion, we found that renal transplantation is now
a safe and effective surgical procedure to help children
with end-stage renal disease. Acute rejection and male sex
were identified as prognostic factors for poor graft survival
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